The own control clinical study on treating 100 cases of BPH with Eviprostat

Zheng Jie,Zhang Yuanfang,Zhang Li,Zhang Yongkang,Liu Zhiyong,Sun Yinghao,Xue Wei,Huang Yiran,Fan Jie,Xia Shujie
DOI: https://doi.org/10.3969/j.issn.1008-0848.2007.06.010
2007-01-01
Abstract:Objectives To evaluate the efficacy and safety of Eviprostat when treating the Benigh Prostatic Hyperplasia (BPH). Methods A multi-centre, open, own-controlled clinic trial was carried out for 12 weeks. The efficacy of 100 cases was evaluated mainly by the International Prostate Syndrome Score (IPSS), the maximum flow rate, the volume of the residual urine and the prostate; secondarily by the Qualily of Life score (QoL), the average flow rate and the rectal touch of prostate. After treated for 12 weeks, the patients were evaluated the efficacy and safety of Eviprostat. Results All had completed the follow-up. Of 100 cases, 36 cases (36%) were remarkably effective, 53 cases (53%) were effective, 9 cases (9%) were improved and 2 cases (2%) were ineffective. Only one patient was found to be dizzy, but was relieved after 3 days. Conclusion The Eviprostat is effective and safe on treating BPH.
What problem does this paper attempt to address?